DBV Technologies (DBVT) EBITDA Margin (2014 - 2026)
DBV Technologies (DBVT) reported EBITDA Margin of 5777.78% for Q1 2026, down 249028.0% year-over-year from N/an in Q1 2025, and up 17.33% on a QoQ basis from 6988.99% in Q4 2025.
DBV Technologies (DBVT) has 11 years of EBITDA Margin data on file, last reported at 5777.78% in Q1 2026.
- Quarterly EBITDA Margin fell 249028.0% year-over-year to 5777.78% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2868.65% (up 34376.0% YoY) and the FY2025 annual result came in at 2487.31%, up 35482.0% from the prior year.
- EBITDA Margin improved to 5777.78% in Q1 2026 per DBVT's latest filing, from 6988.99% in the prior quarter.
- Across five years, EBITDA Margin topped out at 1451.0% in Q4 2022 and bottomed at 6988.99% in Q4 2025.
- The 5-year median for EBITDA Margin is 2162.69% (2024), against an average of 2256.32%.
- The widest annual swing landed in 2022, when EBITDA Margin surged 200489 bps; it then sank 519655 bps in 2024.
- Tracing DBVT's EBITDA Margin over 5 years: stood at 1451.0% in 2022, then tumbled by 104 bps to 55.7% in 2023, then sank by 9330 bps to 5252.25% in 2024, then sank by 33 bps to 6988.99% in 2025, then rose by 17 bps to 5777.78% in 2026.
- Per Business Quant, the three latest DBVT EBITDA Margin figures stand at 5777.78% (Q1 2026), 6988.99% (Q4 2025), and 1225.78% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.35% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.24% |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | -5,777.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,777.78% |
| Dec 31, 2025 | -6,988.99% |
| Sep 30, 2025 | -1,225.78% |
| Jun 30, 2025 | -2,378.23% |
| Mar 31, 2025 | -3,287.50% |
| Dec 31, 2024 | -5,252.25% |
| Sep 30, 2024 | -2,486.75% |
| Jun 30, 2024 | -2,932.90% |
| Mar 31, 2024 | -2,162.69% |
| Dec 31, 2023 | -55.70% |
| Sep 30, 2023 | -870.95% |
| Jun 30, 2023 | -1,069.71% |
| Mar 31, 2023 | -773.79% |
| Dec 31, 2022 | 1,451.00% |
| Sep 30, 2022 | -1,575.31% |
| Jun 30, 2022 | -2,238.98% |
| Mar 31, 2022 | -731.15% |
| Dec 31, 2021 | -553.89% |
| Sep 30, 2021 | -2,096.22% |
| Jun 30, 2021 | -1,869.49% |
| Mar 31, 2021 | -1,301.56% |
| Dec 31, 2020 | 2,424.67% |
| Sep 30, 2020 | -428.91% |
| Jun 30, 2020 | -1,165.26% |
| Mar 31, 2020 | -991.27% |
| Sep 30, 2019 | -1,189.68% |
| Dec 31, 2018 | 474.73% |
| Sep 30, 2018 | -1,476.96% |
| Dec 31, 2015 | -470.57% |
| Jun 30, 2015 | -13,812.04% |
| Dec 31, 2014 | -454.14% |
| Jun 30, 2014 | -11,706.51% |